{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:08:27Z","timestamp":1792706907049,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4710-1","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T10:45:14Z","timestamp":1533552314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines"],"prefix":"10.1186","volume":"18","author":[{"given":"Tomohiro","family":"Kozako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Ohsugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ichiro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"issue":"11","key":"4710_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.tips.2015.08.001","volume":"36","author":"P Gomes","year":"2015","unstructured":"Gomes P, Outeiro TF, Cavadas C. Emerging role of Sirtuin 2 in the regulation of mammalian metabolism. Trends Pharmacol Sci. 2015;36(11):756\u201368.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"4710_CR2","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1073\/pnas.110148297","volume":"97","author":"J Landry","year":"2000","unstructured":"Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A. 2000;97(11):5807\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4710_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0092-8674(00)81671-2","volume":"99","author":"JC Tanny","year":"1999","unstructured":"Tanny JC, Dowd GJ, Huang J, Hilz H, Moazed D. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell. 1999;99(7):735\u201345.","journal-title":"Cell"},{"issue":"4","key":"4710_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccr.2011.09.004","volume":"20","author":"HS Kim","year":"2011","unstructured":"Kim HS, Vassilopoulos A, Wang RH, Lahusen T, Xiao Z, Xu X, Li C, Veenstra TD, Li B, Yu H, et al. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC\/C activity. Cancer Cell. 2011;20(4):487\u201399.","journal-title":"Cancer Cell"},{"issue":"4","key":"4710_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2443.2005.00836.x","volume":"10","author":"N Matsushita","year":"2005","unstructured":"Matsushita N, Takami Y, Kimura M, Tachiiri S, Ishiai M, Nakayama T, Takata M. Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells. Genes Cells. 2005;10(4):321\u201332.","journal-title":"Genes Cells"},{"issue":"2","key":"4710_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/ijo.2015.3275","volume":"48","author":"H Xu","year":"2016","unstructured":"Xu H, Li Y, Chen L, Wang C, Wang Q, Zhang H, Lin Y, Li Q, Pang T. SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1\/2 signaling pathway. Int J Oncol. 2016;48(2):613\u201323.","journal-title":"Int J Oncol"},{"key":"4710_CR7","doi-asserted-by":"publisher","first-page":"27694","DOI":"10.1038\/srep27694","volume":"6","author":"A Deng","year":"2016","unstructured":"Deng A, Ning Q, Zhou L, Liang Y. SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia. Sci Rep. 2016;6:27694.","journal-title":"Sci Rep"},{"key":"4710_CR8","doi-asserted-by":"publisher","first-page":"11345","DOI":"10.1038\/srep11345","volume":"5","author":"T Kozako","year":"2015","unstructured":"Kozako T, Suzuki T, Yoshimitsu M, Uchida Y, Kuroki A, Aikawa A, Honda S, Arima N, Soeda S. Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells. Sci Rep. 2015;5:11345.","journal-title":"Sci Rep"},{"issue":"5","key":"4710_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccr.2008.04.009","volume":"13","author":"CL Brooks","year":"2008","unstructured":"Brooks CL, Gu W. p53 activation: a case against sir. Cancer Cell. 2008;13(5):377\u20138.","journal-title":"Cancer Cell"},{"key":"4710_CR10","doi-asserted-by":"crossref","unstructured":"Uchiyama T: Human T cell leukemia virus type I (HTLV-I) and human diseases. In: Annu Rev Immunol. vol. 15, 1997\/01\/01 edn; 1997: 15\u201337.","DOI":"10.1146\/annurev.immunol.15.1.15"},{"issue":"4","key":"4710_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4):266\u201381.","journal-title":"Lancet Infect Dis"},{"key":"4710_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","volume":"19","author":"M Yoshida","year":"2001","unstructured":"Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol. 2001;19:475\u201396.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"4710_CR13","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.4049\/jimmunol.177.8.5718","volume":"177","author":"T Kozako","year":"2006","unstructured":"Kozako T, Arima N, Toji S, Masamoto I, Akimoto M, Hamada H, Che XF, Fujiwara H, Matsushita K, Tokunaga M, et al. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J Immunol. 2006;177(8):5718\u201326.","journal-title":"J Immunol"},{"issue":"2","key":"4710_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/leu.2008.272","volume":"23","author":"T Kozako","year":"2009","unstructured":"Kozako T, Yoshimitsu M, Fujiwara H, Masamoto I, Horai S, White Y, Akimoto M, Suzuki S, Matsushita K, Uozumi K, et al. PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients. Leukemia. 2009;23(2):375\u201382.","journal-title":"Leukemia"},{"issue":"39","key":"4710_CR15","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","volume":"24","author":"GP Taylor","year":"2005","unstructured":"Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene. 2005;24(39):6047\u201357.","journal-title":"Oncogene"},{"issue":"4","key":"4710_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4710_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984-87). Br J Haematol. 1991;79(3):428\u201337.","journal-title":"Br J Haematol"},{"issue":"24","key":"4710_CR18","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126(24):2570\u20137.","journal-title":"Blood"},{"issue":"34","key":"4710_CR19","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, Ikeda S, Masuda M, Nagoshi H, Ueda R, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801. J Clin Oncol. 2007;25(34):5458\u201364.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4710_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan clinical oncology group study 9303. Br J Haematol. 2001;113(2):375\u201382.","journal-title":"Br J Haematol"},{"key":"4710_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-642-38965-8_12","volume":"193","author":"M Yoshimitsu","year":"2014","unstructured":"Yoshimitsu M, White Y, Arima N. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia\/lymphoma. Recent Results Cancer Res. 2014;193:211\u201325.","journal-title":"Recent Results Cancer Res"},{"issue":"16","key":"4710_CR22","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1016\/j.bmc.2009.07.001","volume":"17","author":"T Suzuki","year":"2009","unstructured":"Suzuki T, Imai K, Imai E, Iida S, Ueda R, Tsumoto H, Nakagawa H, Miyata N. Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors. Bioorg Med Chem. 2009;17(16):5900\u20135.","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"4710_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.exphem.2003.11.008","volume":"32","author":"N Arima","year":"2004","unstructured":"Arima N, Arimura K, Tokito Y, Sakaki Y, Matsushita K, Orihara K, Akimoto M, Ozaki A, Kukita T, Hagiwara T, et al. HTLV-I tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells. Exp Hematol. 2004;32(2):195\u2013201.","journal-title":"Exp Hematol"},{"issue":"5843","key":"4710_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981;294(5843):770\u20131.","journal-title":"Nature"},{"issue":"12","key":"4710_CR25","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1021\/jm3002108","volume":"55","author":"T Suzuki","year":"2012","unstructured":"Suzuki T, Khan MN, Sawada H, Imai E, Itoh Y, Yamatsuta K, Tokuda N, Takeuchi J, Seko T, Nakagawa H, et al. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem. 2012;55(12):5760\u201373.","journal-title":"J Med Chem"},{"issue":"9","key":"4710_CR26","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/ijc.27481","volume":"131","author":"T Kozako","year":"2012","unstructured":"Kozako T, Aikawa A, Shoji T, Fujimoto T, Yoshimitsu M, Shirasawa S, Tanaka H, Honda S, Shimeno H, Arima N, et al. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer. 2012;131(9):2044\u201355.","journal-title":"Int J Cancer"},{"issue":"2\u20133","key":"4710_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molimm.2009.09.006","volume":"47","author":"T Kozako","year":"2009","unstructured":"Kozako T, Fukada K, Hirata S, White Y, Harao M, Nishimura Y, Kino Y, Soeda S, Shimeno H, Lemonnier F, et al. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia. Mol Immunol. 2009;47(2\u20133):606\u201313.","journal-title":"Mol Immunol"},{"issue":"8","key":"4710_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1742-4658.2011.08055.x","volume":"278","author":"T Kozako","year":"2011","unstructured":"Kozako T, Hirata S, Shimizu Y, Satoh Y, Yoshimitsu M, White Y, Lemonnier F, Shimeno H, Soeda S, Arima N. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. FEBS J. 2011;278(8):1358\u201366.","journal-title":"FEBS J"},{"issue":"9","key":"4710_CR29","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.4161\/auto.21028","volume":"8","author":"LL Chan","year":"2012","unstructured":"Chan LL, Shen D, Wilkinson AR, Patton W, Lai N, Chan E, Kuksin D, Lin B, Qiu J. A novel image-based cytometry method for autophagy detection in living cells. Autophagy. 2012;8(9):1371\u201382.","journal-title":"Autophagy"},{"issue":"3","key":"4710_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/leu.2013.264","volume":"28","author":"MV Stankov","year":"2014","unstructured":"Stankov MV, El Khatib M, Kumar Thakur B, Heitmann K, Panayotova-Dimitrova D, Schoening J, Bourquin JP, Schweitzer N, Leverkus M, Welte K, et al. Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia. 2014;28(3):577\u201388.","journal-title":"Leukemia"},{"issue":"5381","key":"4710_CR31","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281(5381):1309\u201312.","journal-title":"Science"},{"issue":"2\u20133","key":"4710_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0300-9084(02)01369-X","volume":"84","author":"C Fleury","year":"2002","unstructured":"Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84(2\u20133):131\u201341.","journal-title":"Biochimie"},{"issue":"7","key":"4710_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nm1263","volume":"11","author":"G Kroemer","year":"2005","unstructured":"Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med. 2005;11(7):725\u201330.","journal-title":"Nat Med"},{"issue":"50","key":"4710_CR34","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1038\/onc.2008.311","volume":"27","author":"SW Tait","year":"2008","unstructured":"Tait SW, Green DR. Caspase-independent cell death: leaving the set without the final cut. Oncogene. 2008;27(50):6452\u201361.","journal-title":"Oncogene"},{"issue":"7","key":"4710_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.tcb.2011.03.007","volume":"21","author":"JM Gump","year":"2011","unstructured":"Gump JM, Thorburn A. Autophagy and apoptosis: what is the connection? Trends Cell Biol. 2011;21(7):387\u201392.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"4710_CR36","first-page":"15","volume":"1","author":"SH Park","year":"2012","unstructured":"Park SH, Zhu Y, Ozden O, Kim HS, Jiang H, Deng CX, Gius D, Vassilopoulos A. SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis. Transl Cancer Res. 2012;1(1):15\u201321.","journal-title":"Transl Cancer Res"},{"issue":"9","key":"4710_CR37","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1128\/MCB.23.9.3173-3185.2003","volume":"23","author":"SC Dryden","year":"2003","unstructured":"Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol. 2003;23(9):3173\u201385.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4710_CR38","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbrc.2011.11.141","volume":"417","author":"X He","year":"2012","unstructured":"He X, Nie H, Hong Y, Sheng C, Xia W, Ying W. SIRT2 activity is required for the survival of C6 glioma cells. Biochem Biophys Res Commun. 2012;417(1):468\u201372.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4710_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2443.2010.01460.x","volume":"16","author":"Y Li","year":"2011","unstructured":"Li Y, Matsumori H, Nakayama Y, Osaki M, Kojima H, Kurimasa A, Ito H, Mori S, Katoh M, Oshimura M, et al. SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells. 2011;16(1):34\u201345.","journal-title":"Genes Cells"},{"issue":"12","key":"4710_CR40","doi-asserted-by":"publisher","first-page":"20295","DOI":"10.3390\/molecules191220295","volume":"19","author":"T Kozako","year":"2014","unstructured":"Kozako T, Suzuki T, Yoshimitsu M, Arima N, Honda SI, Soeda S. Anticancer agents targeted to Sirtuins. Molecules. 2014;19(12):20295\u2013313.","journal-title":"Molecules"},{"issue":"8","key":"4710_CR41","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1074\/jbc.M113.487736","volume":"289","author":"G Hoffmann","year":"2014","unstructured":"Hoffmann G, Breitenbucher F, Schuler M, Ehrenhofer-Murray AE. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer. J Biol Chem. 2014;289(8):5208\u201316.","journal-title":"J Biol Chem"},{"issue":"10","key":"4710_CR42","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1248\/bpb.b16-00520","volume":"39","author":"AA Shah","year":"2016","unstructured":"Shah AA, Ito A, Nakata A, Yoshida M. Identification of a selective SIRT2 inhibitor and its anti-breast Cancer activity. Biol Pharm Bull. 2016;39(10):1739\u201342.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"4710_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejca.2013.10.005","volume":"50","author":"LM McGlynn","year":"2014","unstructured":"McGlynn LM, Zino S, MacDonald AI, Curle J, Reilly JE, Mohammed ZM, McMillan DC, Mallon E, Payne AP, Edwards J, et al. SIRT2: tumour suppressor or tumour promoter in operable breast cancer? Eur J Cancer. 2014;50(2):290\u2013301.","journal-title":"Eur J Cancer"},{"issue":"5497","key":"4710_CR44","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290(5497):1717\u201321.","journal-title":"Science"},{"issue":"4","key":"4710_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","volume":"6","author":"B Levine","year":"2004","unstructured":"Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6(4):463\u201377.","journal-title":"Dev Cell"},{"issue":"1","key":"4710_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2013.169","volume":"24","author":"Y Ohsumi","year":"2014","unstructured":"Ohsumi Y. Historical landmarks of autophagy research. Cell Res. 2014;24(1):9\u201323.","journal-title":"Cell Res"},{"issue":"7","key":"4710_CR47","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuint.2012.07.010","volume":"61","author":"J Gal","year":"2012","unstructured":"Gal J, Bang Y, Choi HJ. SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition. Neurochem Int. 2012;61(7):992\u20131000.","journal-title":"Neurochem Int"},{"issue":"11","key":"4710_CR48","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1111\/febs.12810","volume":"281","author":"T Inoue","year":"2014","unstructured":"Inoue T, Nakayama Y, Li Y, Matsumori H, Takahashi H, Kojima H, Wanibuchi H, Katoh M, Oshimura M. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors. FEBS J. 2014;281(11):2623\u201337.","journal-title":"FEBS J"},{"issue":"9","key":"4710_CR49","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait SW, Green DR. Mitochondria and cell death: outer membran permeabilization and beyond. Nat Rev Mol Cell Biol. 2010;11(9):621\u201332.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4710-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:12:43Z","timestamp":1565032363000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4710-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4710"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4710-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any experiments with human participants or animal performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"791"}}